Literature DB >> 2994530

Neutral metalloendopeptidase in human lung tissue and cultured cells.

A R Johnson, J Ashton, W W Schulz, E G Erdös.   

Abstract

The distribution of a neutral metalloendopeptidase (NEP), or "enkephalinase," in human lung tissue and cultured cells was compared with that of angiotensin I converting enzyme (ACE). The specific activities of NEP and ACE were measured in homogenates of fetal lung tissue and in isolated airways and pulmonary vessels. NEP activity was highest in airway tissue, and ACE activity was highest in isolated vessels. Human endothelial cells from either umbilical veins or pulmonary arteries had high ACE activity (80 to 90 nmol/h/10(6) cells) but only a trace of NEP activity (0.5 to 0.6 nmol/h/10(6) cells). Fibroblasts cultured from human lungs were low in ACE but richer in NEP than cultured endothelial cells. Fibroblasts from human foreskins or caesarean section skin were the richest source of NEP activity (60 to 80 nmol/h/10(6) cells). Immunohistochemical studies confirmed the biochemical assays. As expected, ACE was localized on the luminal surface of blood vessels, with a distribution similar to that of factor VIII antigen, an endothelial marker. In contrast, NEP was localized within the alveolar septa. Cultured endothelial cells stained only weakly for NEP in contrast to cultured fibroblasts. The location of these 2 enzymes in different cells and the differences in peptide substrate specificity suggests that they act sequentially on circulating peptides or those released within microvascular beds.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994530     DOI: 10.1164/arrd.1985.132.3.564

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  56 in total

1.  Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects.

Authors:  G M Nichol; B J O'Connor; J M Lecomte; K F Chung; P J Barnes
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Modulation of bradykinin responses in airway smooth muscle by epithelial enzymes.

Authors:  N Frossard; C D Stretton; P J Barnes
Journal:  Agents Actions       Date:  1990-11

3.  Effect of inhaled thiorphan, a neutral endopeptidase inhibitor, on the bronchodilator response to inhaled atrial natriuretic peptide (ANP).

Authors:  R M Angus; E A Millar; G W Chalmers; N C Thomson
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

4.  Effects of hyperosmolarity on human isolated central airways.

Authors:  R C Jongejan; J C de Jongste; R C Raatgeep; T Stijnen; I L Bonta; K F Kerrebijn
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

5.  Neutral endopeptidase-like enzyme controls the contractile activity of substance P in guinea pig lung.

Authors:  N P Stimler-Gerard
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.

Authors:  R K Ganju; M Sunday; D G Tsarwhas; A Card; M A Shipp
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP.

Authors:  A Ben-Jebria; R Marthan; M Rossetti; J P Savineau
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  Functional effects of phosphoramidon and captopril on exogenous neuropeptides in human nasal mucosa.

Authors:  C Châtelain; N Pochon; J S Lacroix
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

9.  Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma.

Authors:  N Crimi; R Polosa; G Pulvirenti; S Magrì; G Santonocito; G Prosperini; C Mastruzzo; A Mistretta
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

10.  Tissue inhibitor of metalloproteinases and collagenase inhibitory activity in lung secretions from patients with chronic obstructive bronchitis: effect of corticosteroid treatment.

Authors:  D Burnett; J J Reynolds; R V Ward; S C Afford; R A Stockley
Journal:  Thorax       Date:  1986-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.